Primerica reported a 21% increase in total revenues, reaching $724.1 million, and a 20% increase in diluted adjusted operating EPS to $2.94. The company faced headwinds in its Senior Health segment, resulting in a $76 million goodwill impairment charge. The Board of Directors approved an increase of $50 million to the share repurchase program.
Total revenues increased by 21% to $724.1 million compared to Q4 2020.
Diluted adjusted operating EPS rose by 20% to $2.94.
A preliminary non-cash goodwill impairment charge of $76 million was recorded in the Senior Health segment.
The Board of Directors approved an additional $50 million for share repurchases.
The board of directors has authorized the repurchase of an additional $50 million of the company’s common stock, bringing the total amount authorized through December 2022 to $325 million, of which $19 million was deployed during the fourth quarter of 2021. In addition, as announced on February 8, 2022, the board of directors has approved an increase of 17% in stockholder dividends to $0.55 per share, payable on March 14, 2022, to stockholders of record on February 22, 2022.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance